| P50 | author | David S Siscovick | Q86839898 |
| | Cora E Lewis | Q87075032 |
| | Pamela J Schreiner | Q90045525 |
| | Adam Williams | Q99616314 |
| | Marcelle I Cedars | Q107649328 |
| | Ronit Calderon-Margalit | Q108871253 |
| | Barbara Sternfeld | Q110251076 |
| | Erica T. Wang | Q117266159 |
| | Sharon Stein Merkin | Q37322634 |
| | Stephen Schwartz | Q43098294 |
| | Kirsten Bibbins-Domingo | Q56027904 |
| | Martha L. Daviglus | Q63255347 |
| P2093 | author name string | Melissa Wellons | |
| P2860 | cites work | Testosterone-Binding Levels in the Serum of Women During the Normal Menstrual Cycle, Pregnancy, and the Post-partum Period | Q72228175 |
| | Women with polycystic ovary syndrome gain regular menstrual cycles when ageing | Q73302347 |
| | Polycystic ovary syndrome: validated questionnaire for use in diagnosis | Q24679646 |
| | Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 |
| | Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women | Q34489447 |
| | Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis | Q36899403 |
| | Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. | Q37023259 |
| | Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? | Q37212024 |
| | CARDIA: study design, recruitment, and some characteristics of the examined subjects | Q39292643 |
| | Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study | Q39593191 |
| | Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome | Q40355988 |
| | Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus | Q40671792 |
| | Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites. The role of insulin | Q41299633 |
| | Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling | Q42472147 |
| | Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease | Q42472403 |
| | Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome | Q43832908 |
| | Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study | Q44883226 |
| | Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. | Q51557446 |
| | Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 |
| | Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection. | Q51724086 |
| | Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. | Q52097851 |
| | Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? | Q71161856 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polycystic ovary | Q5547896 |
| | polycystic ovary syndrome | Q500816 |
| | dyslipidemia | Q66291209 |
| P304 | page(s) | 6-13 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Obstetrics and Gynecology | Q7075543 |
| P1476 | title | Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia | |
| P478 | volume | 117 | |